Eli Lilly’s rheumatoid arthritis drug accelerates recovery in COVID-19 patients – Reuters UK
Eli Lilly and Co said on Monday its rheumatoid arthritis drug shortened the recovery time for hospitalized COVID-19 patients also given Gilead Sciences Inc’s antiviral remdesivir.
